Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab.
Jackson DJ, Burhan H, Rupani H, Pfeffer PE, Clifton IJ, Faruqi S, Dhariwal J, Patel P, Morris T, Lipworth J, Watt M, Lupton C, Dube S, Hickey J, Nanzer AM.
Jackson DJ, et al. Among authors: hickey j.
Clin Exp Allergy. 2024 Oct;54(10):734-746. doi: 10.1111/cea.14544. Epub 2024 Jul 31.
Clin Exp Allergy. 2024.
PMID: 39084909